When It's More Than an Urge

Would popping daily citaloprams, I wonder, have restrained Jackie Kennedy's celebrated spending sprees and prevented the purported ensuing marital discord? How about a fluvoxamine prescription? Or natrexone? And what about publisher William Randolph Hearst who, at the peak of his purchasing power in the 1920s, spent $15 million a year? Even after achieving near bankruptcy, Hearst continued feeding his mania for antiquities, tapestries, oriental rugs, paintings, and other collectibles. Would medd

Written byLeslie Pray
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Would popping daily citaloprams, I wonder, have restrained Jackie Kennedy's celebrated spending sprees and prevented the purported ensuing marital discord? How about a fluvoxamine prescription? Or natrexone? And what about publisher William Randolph Hearst who, at the peak of his purchasing power in the 1920s, spent $15 million a year? Even after achieving near bankruptcy, Hearst continued feeding his mania for antiquities, tapestries, oriental rugs, paintings, and other collectibles. Would meddling with a remedy to restore what some consider a chemical imbalance in the brain have tempered the nearly (some would say definitively) self-destructive shopaholic behavior of this 20th century tycoon?

We'll never know. But some day, psychiatrists may know enough to begin prescribing drugs to treat so-called compulsive shopping disorder, a condition that affects millions of Americans. After all, the rich and famous aren't the only ones who spend, spend, and continue to spend, even as their compulsion leads ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies